Kooman J - Search Results

1

Mixed matrix membranes: a new asset for blood purification therapies.

Tijink MS, Kooman J, Wester M, Sun J, Saiful S, Joles JA, Borneman Z, Wessling M, Stamatialis DF. Tijink MS, et al. Among authors: kooman j. Blood Purif. 2014;37(1):1-3. doi: 10.1159/000356226. Epub 2014 Jan 4. Blood Purif. 2014. PMID: 24401819 Free article. No abstract available.

2

Development of novel membranes for blood purification therapies based on copolymers of N-vinylpyrrolidone and n-butylmethacrylate.

Tijink M , Janssen J , Timmer M , Austen J , Aldenhoff Y , Kooman J , Koole L , Damoiseaux J , van Oerle R , Henskens Y , Stamatialis D . Tijink M , et al. Among authors: kooman j. J Mater Chem B. 2013 Nov 28;1(44):6066-6077. doi: 10.1039/c3tb20964d. Epub 2013 Oct 7. J Mater Chem B. 2013. PMID: 32260991

3

A regenerable potassium and phosphate sorbent system to enhance dialysis efficacy and device portability: an in vitro study.

Wester M, Simonis F, Gerritsen KG, Boer WH, Wodzig WK, Kooman JP, Joles JA. Wester M, et al. Nephrol Dial Transplant. 2013 Sep;28(9):2364-71. doi: 10.1093/ndt/gft205. Epub 2013 Jul 3. Nephrol Dial Transplant. 2013. PMID: 23825104

4

Creating a wearable artificial kidney: where are we now?

Kooman JP, Joles JA, Gerritsen KG. Kooman JP, et al. Expert Rev Med Devices. 2015 Jul;12(4):373-6. doi: 10.1586/17434440.2015.1053466. Expert Rev Med Devices. 2015. PMID: 26076370

5

Removal of urea in a wearable dialysis device: a reappraisal of electro-oxidation.

Wester M, Simonis F, Lachkar N, Wodzig WK, Meuwissen FJ, Kooman JP, Boer WH, Joles JA, Gerritsen KG. Wester M, et al. Among authors: kooman jp. Artif Organs. 2014 Dec;38(12):998-1006. doi: 10.1111/aor.12309. Epub 2014 Apr 21. Artif Organs. 2014. PMID: 24750025

6

[The wearable artificial kidney: a promise for the future?].

Wester M, Gerritsen KG, Boer WH, Joles JA, Kooman JP. Wester M, et al. Ned Tijdschr Geneeskd. 2013;157(52):A6965. Ned Tijdschr Geneeskd. 2013. PMID: 24382046 Dutch.

7

[The wearable artificial kidney: what is the current state of play?].

Wester M, van Gelder MK, Joles JA, Verhaar MC, Kooman JP, Gerritsen KGF. Wester M, et al. Ned Tijdschr Geneeskd. 2019 Jul 4;163:D3728. Ned Tijdschr Geneeskd. 2019. PMID: 31283124 Dutch.

8

Vascular access vulnerability in intensive hemodialysis: a significant Achilles' heel?

Cornelis T, Usvyat LA, Tordoir JH, Wang Y, Wong M, Leunissen KM, van der Sande FM, Kotanko P, Kooman JP. Cornelis T, et al. Blood Purif. 2014;37(3):222-8. doi: 10.1159/000362106. Epub 2014 Jun 5. Blood Purif. 2014. PMID: 24902990 Free article. Review.

9

Effects of ultrapure hemodialysis and low molecular weight heparin on the endothelial surface layer.

Cornelis T, Broers NJ, Titulaer DC, Henskens YM, van Oerle R, van der Sande FM, Spronk HM, Vink H, Leunissen KM, ten Cate H, Kooman JP. Cornelis T, et al. Among authors: kooman jp. Blood Purif. 2014;38(3-4):203-10. doi: 10.1159/000369055. Epub 2014 Dec 16. Blood Purif. 2014. PMID: 25531879

10

Nitric oxide synthetic capacity in relation to dialysate temperature.

Beerenhout CH, Noris M, Kooman JP, Porrati F, Binda E, Morigi M, Bekers O, van der Sande FM, Todeschini M, Macconi D, Leunissen KM, Remuzzi G. Beerenhout CH, et al. Blood Purif. 2004;22(2):203-9. doi: 10.1159/000076854. Blood Purif. 2004. PMID: 15044819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

356 results

Search Page